| 883 | 2 | 58 |
| 下载次数 | 被引频次 | 阅读次数 |
免疫逃逸是引发肿瘤转移和复发的关键因素，目前免疫治疗逐渐成为癌症治疗的新途径并在临床治疗中效果显著。天然产物是药物开发的重要来源，在癌症免疫治疗中显示出多种生物活性和巨大潜力。大量研究发现天然产物在多种癌症类型中可以通过直接调控固有免疫细胞和适应性免疫细胞，或通过调节相关细胞因子和信号通路等多种方式间接调控免疫细胞活性，以重塑肿瘤微环境，增强免疫系统的免疫监视能力，进而抑制肿瘤免疫逃逸过程。此综述天然产物通过调控免疫细胞参与肿瘤免疫逃逸的作用机制，以期为研发肿瘤免疫治疗新策略提供用药指导和思路。
Abstract：Immune escape is a key factor leading to tumor metastasis and recurrence. At present, immunotherapy has gradually become a new way of cancer treatment and has achieved remarkable results in clinical treatment. Natural products are an important source of drug development, showing a variety of biological activities and great potential in cancer immunotherapy. A large number of studies have found that natural products can indirectly regulate the activity of immune cells in a variety of cancer types by directly regulating innate immune cells and adaptive immune cells, or by regulating related cytokines and signaling pathways, so as to reshape the tumor microenvironment, enhance the immune surveillance ability of the immune system, and then inhibit the tumor immune escape process. Therefore, the mechanism of natural products participating in tumor immune escape by regulating immune cells is reviewed in order to provide medication guidance and ideas for the development of new strategies for tumor immunotherapy.
1 Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229‐263.
2 Soerjomataram I,Bray F.Planning for tomorrow:Glob‐al cancer incidence and the role of prevention 2020‐2070[J].Nat Rev Clin Oncol,2021,18(10):663‐672.
3 Maomao C,He L,Dianqin S,et al.Current cancer bur‐den in China:Epidemiology,etiology,and prevention[J].Cancer Biol Med,2022,19(8):1121‐1138.
4 Rui R,Zhou L,He S.Cancer immunotherapies:Ad‐vances and bottlenecks[J].Front Immunol,2023,14:1212476.
5 Gupta M,Chandan K,Sarwat M.Natural products and their derivatives as immune check point inhibitors:Tar‐geting cytokine/chemokine signalling in cancer[J].Semin Cancer Biol,2022,86(Pt 2):214‐232.
6 Tian W,Huang J,Zhang W,et al.Harnessing natural product polysaccharides against lung cancer and revisit its novel mechanism[J].Pharmacol Res,2024,199:107034.
7 Ahmadi M,Abbasi R,Rezaie J.Tumor immune es‐cape:Extracellular vesicles roles and therapeutics appli‐cation[J].Cell Commun Signal,2024,22(1):9.
8 Buzas EI.The roles of extracellular vesicles in the im‐mune system[J].Nat Rev Immunol,2023,23(4):236‐250.
9 Yi M,Li T,Niu M,et al.Exploiting innate immunity for cancer immunotherapy[J].Mol Cancer,2023,22(1):187.
10 Miao S,Zhang Q.Circulating circ RNA:A social butter‐fly in tumors[J].Front Oncol,2023,13:1203696.
11 Liu H,Ouyang Z,Li S.Advances of M1 macrophages‐derived extracellular vesicles in tumor therapy[J].Biomed Pharmacother,2024,181:117735.
12 Toledo B,Zhu Chen L,Paniagua‐Sancho M.Decipher‐ing the performance of macrophages in tumour microenvi‐ronment:A call for precision immunotherapy[J].J He‐matol Oncol,2024,17(1):44.
13 Gao J,Liang Y,Wang L.Shaping polarization of tumor‐associated macrophages in cancer immunotherapy[J].Front Immunol,2022,13:888713.
14 Zhao Z,Zhao G,Yang S,et al.The significance of exo‐somal RNAs in the development,diagnosis,and treat‐ment of pancreatic cancer[J].Cancer Cell Int,2021,21(1):364.
15 Shi Y,Hao D,Qian H,et al.Natural killer cell‐based cancer immunotherapy:From basics to clinical trials[J].Exp Hematol Oncol,2024,13(1):101.
16 Momayyezi P,Bilev E,Ljunggren HG,et al.Viral es‐cape from NK‐cell‐mediated immunosurveillance:A les‐son for cancer immunotherapy?[J].Eur J Immunol,2023,53(11):e2350465.
17 Huang P,Zhu S,Liang X,et al.Revisiting lung cancer metastasis:Insight from the functions of long non‐coding RNAs[J].Technol Cancer Res Treat,2021,20:15330338211038488.
18 Lu J,Luo Y,Rao D,et al.Myeloid‐derived suppressor cells in cancer:Therapeutic targets to overcome tumor immune evasion[J].Exp Hematol Oncol,2024,13(1):39.
19 Saura‐Esteller J,de Jong M,King LA,et al.Gamma delta T‐cell based cancer immunotherapy:Past‐present‐future[J].Front Immunol,2022,13:915837.
20 Li Z,Lin A,Gao Z,et al.B‐cell performance in chemo‐therapy:Unravelling the mystery of B‐cell therapeutic potential[J].Clin Transl Med,2024,14(7):e1761.
21 Rastogi I,Jeon D,Moseman JE,et al.Role of B cells as antigen presenting cells[J].Front Immunol,2022,13:954936.
22 Chan WJ,Adiwidjaja J,Mc Lachlan AJ,et al.Interac‐tions between natural products and cancer treatments:Underlying mechanisms and clinical importance[J].Can‐cer Chemother Pharmacol,2023,91(2):103‐119.
23 Song L,Zhang W,Tang SY,et al.Natural products in traditional Chinese medicine:Molecular mechanisms and therapeutic targets of renal fibrosis and state‐of‐the‐art drug delivery systems[J].Biomed Pharmacother,2024,170:116039.
24 Sflakidou E,Leonidis G,Foroglou E,et al.Recent ad‐vances in natural product‐based hybrids as anti‐cancer agents[J].Molecules,2022,27(19):6632.
25 Xu F,Cui WQ,Wei Y,et al.AstragalosideⅣinhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling[J].JExp Clin Cancer Res,2018,37(1):207.
26 Tian H,Liu Z,Pu Y,et al.Immunomodulatory effects exerted by Poria cocos polysaccharides via TLR4/TRAF6/NF‐κB signaling in vitro and in vivo[J].Biomed Pharmacother,2019,112:108709.
27 Im DS.Pro‐resolving effect of ginsenosides as an anti‐inflammatory mechanism of Panax ginseng[J].Bio‐molecules,2020,10(3):444.
28 Talib WH,Alsayed AR,Farhan F,et al.Resveratrol and tumor microenvironment:Mechanistic basis and therapeutic targets[J].Molecules,2020,25(18):4282.
29 Chang WT,Lai TH,Chyan YJ,et al.Specific medici‐nal plant polysaccharides effectively enhance the potency of a DC‐based vaccine against mouse mammary tumor metastasis[J].PLo S One,2015,10(3):e0122374.
30王绪麟，李慧璇，王丽华，等.苦参碱联合DC‐CIK细胞对乳腺癌细胞的杀伤作用[J].中国临床药理学杂志，2023,39(16):2311‐2315.Wang XL,Li HX,Wang LH,et al.Killing effect of matrine combined with DC‐CIK cells on breast cancer cells[J].Chin J Clin Pharmacol,2023,39 (16):2311‐2315.
31 Gao J,Zhang YN,Cui J,et al.A polysaccharide from the whole plant of Plantago asiatica L.enhances the anti‐tumor activity of dendritic cell‐based immunotherapy against breast cancer[J].Front Pharmacol,2021,12:678865.
32俞永婷，娜迪热木·肖克拉提，卢泳强，等.胀果甘草多糖佐助的树突状细胞疫苗对H22肝癌荷瘤小鼠的免疫治疗作用[J].中国医院药学杂志，2024,44(1):35‐41.Yu YT,Nadiremu XKLT,Lu YQ,et al.Immunotherapeutic effect of dendritic cell vaccine assisted by Glycyrrhiza inflata polysaccharides in H22hepatoma‐bearing mice[J].Chin J Hosp Pharm,2024,44(1):35‐41.
33 Ooi SL,Micalos PS,Kim J,et al.Rice bran arabinox‐ylan compound as a natural product for cancer treatment‐an evidence‐based assessment of the effects and mecha‐nisms[J].Pharm Biol,2024,62(1):367‐393.
34 Wang N,Yang J,Lu J,et al.A polysaccharide from Salvia miltiorrhiza Bunge improves immune function in gastric cancer rats[J].Carbohydr Polym,2014,111:47‐55.
35 Wu XT,Liu JQ,Lu XT,et al.The enhanced effect of lupeol on the destruction of gastric cancer cells by NKcells[J].Int Immunopharmacol,2013,16(2):332‐340.
36 Zhang HG,Kim H,Liu C,et al.Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity[J].Biochim Biophys Acta,2007,1773(7):1116‐1123.
37 Zhang W,He W,Shi X,et al.An Asparagus polysac‐charide fraction inhibits MDSCs by inducing apoptosis through toll‐like receptor 4[J].Phytother Res,2018,32(7):1297‐1303.
38 Zhao Y,Shao Q,Zhu H,et al.Resveratrol ameliorates Lewis lung carcinoma‐bearing mice development,de‐creases granulocytic myeloid‐derived suppressor cell ac‐cumulation and impairs its suppressive ability[J].Cancer Sci,2018,109(9):2677‐2686.
39 Wu T,Liu W,Guo W,et al.Silymarin suppressed lung cancer growth in mice via inhibiting myeloid‐derived sup‐pressor cells[J].Biomed Pharmacother,2016,81:460‐467.
40 Wang Y,Fan X,Wu X.Ganoderma lucidum polysac‐charide (GLP) enhances antitumor immune response by regulating differentiation and inhibition of MDSCs via a CARD9‐NF‐κB‐IDO pathway[J].Biosci Rep,2020,40(6):BSR20201170.
41 Wang C,Shi S,Chen Q,et al.Antitumor and immuno‐modulatory activities of Ganoderma lucidum polysaccha‐rides in glioma‐bearing rats[J].Integr Cancer Ther,2018,17(3):674‐683.
42 Zhao X,Liu J,Ge S,et al.Saikosaponin A inhibits breast cancer by regulating Th1/Th2 balance[J].Front Pharmacol,2019,10:624.
43 Zhuang H,Dai X,Zhang X,et al.Sophoridine suppress‐es macrophage‐mediated immunosuppression through TLR4/IRF3 pathway and subsequently upregulates CD8+T cytotoxic function against gastric cancer[J].Biomed Pharmacother,2020,121:109636.
44 Wang M,Yan SJ,Zhang HT,et al.Ginsenoside Rh2enhances the antitumor immunological response of a mel‐anoma mice model[J].Oncol Lett,2017,13(2):681‐685.
45 Nelson N,Szekeres K,Iclozan C,et al.Apigenin:Se‐lective CK2 inhibitor increases Ikaros expression and im‐proves T cell homeostasis and function in murine pancre‐atic cancer[J].PLo S One,2017,12(2):e0170197.
46 Liao F,Liu L,Luo E,et al.Curcumin enhances anti‐tumor immune response in tongue squamous cell car‐cinoma[J].Arch Oral Biol,2018,92:32‐37.
47 Liu P,Zhao M,Lin Y,et al.Platycodin D induces pro‐liferation inhibition and mitochondrial apoptosis in diffuse large B‐cell lymphoma[J].Exp Hematol,2023,123:46‐55.e1.
48 Aghvami M,Ebrahimi F,Zarei MH,et al.Matrine in‐duction of ROS mediated apoptosis in human ALLB‐lymphocytes via mitochondrial targeting[J].Asian Pac J Cancer Prev,2018,19(2):555‐560.
49 Shi X,Lan X,Chen X,et al.Gambogic acid induces apoptosis in diffuse large B‐cell lymphoma cells via in‐ducing proteasome inhibition[J].Sci Rep,2015,5:9694.
基本信息:
DOI：10.13210/j.cnki.jhmu.20250305.002
中图分类号:R730.51
引用信息:
[1]谢瑛莹,李东东,张晓青,等.天然产物调控免疫细胞参与肿瘤免疫逃逸的作用机制研究进展[J].海南医科大学学报,2025,31(13):1032-1040.DOI:10.13210/j.cnki.jhmu.20250305.002.
基金信息:
国家自然科学基金资助项目（82204981）; 河南省特色骨干学科中医学学科建设项目（STG-ZYX06-202145）; 河南省中医药科学研究专项课题（2021JDZX2002）;河南省中医药科学研究专项课题（20-21ZY2115）; 河南省中医院博士科研基金（2022BSJJ07）;河南省中医院博士科研基金（2023BSJJ02）; 河南中医药大学2022年度研究生科研创新能力提升计划项目（2022KYCX057）; 河南中医药大学2023年度研究生科研创新能力提升计划项目（2023KYCX043）;河南中医药大学2023年度研究生科研创新能力提升计划项目（2023KYCX051）~~
2025-03-06
2025-03-06
2025-03-06